Journal article
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study
Abstract
In adult hematopoietic cell transplantation (HCT), filgrastim-mobilized peripheral blood (G-PB) has largely replaced unstimulated marrow for allografting. Although the use of G-PB results in faster hematopoietic recovery, it is also associated with more chronic graft-versus-host disease (cGVHD). A potential alternative allograft is filgrastim-stimulated marrow (G-BM), which we hypothesized may be associated with prompt hematopoietic recovery …
Authors
Couban S; Aljurf M; Lachance S; Walker I; Toze C; Rubinger M; Lipton JH; Lee SJ; Szer J; Doocey R
Journal
Transplantation and Cellular Therapy, Vol. 22, No. 8, pp. 1410–1415
Publisher
Elsevier
Publication Date
8 2016
DOI
10.1016/j.bbmt.2016.04.017
ISSN
2666-6367
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAdultAgedBone MarrowBone Marrow TransplantationFemaleFilgrastimGraft SurvivalGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell MobilizationHumansMaleMiddle AgedMyeloablative AgonistsPeripheral Blood Stem Cell TransplantationSiblingsSurvival RateTransplantation, HomologousTreatment OutcomeYoung Adult